Compound Name (alphabetical) | Enz. Inhib. Data | ITC Data | Binding Targets | Alternate Compound Names |
---|
Ki | IC50 | Kd | EC50 | Koff | Kon | Other |
---|
BDBM10016
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Carbonic anhydrase 2
- Cytochrome P450 19A1
| - 4-{[(4-bromophenyl)methyl](4H-1,2,4-triazol-4-yl)amino}benzonitrile
- YM511
|
BDBM10019
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Cytochrome P450 19A1
- Steryl-sulfatase
| - (2-chloro-4-{[(4-cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl) sulfamate
- JMC503540 Compound 4
- YM511-based dual aromatase-sulfatase inhibitor (DASI) 6
- dual aromatase-sulfatase inhibitor 6
|
BDBM100205
 | 0 | 2 | 1 | 3 | 0 | 0 | 0 | 0 | - Alpha trans-inducing protein (VP16)
- COUP transcription factor 2 isoform a
- Cystic fibrosis transmembrane conductance regulator
| - MLS000561583
- N-[5-[2-(5-chloro-2-methoxy-anilino)thiazol-4-yl]-4-methyl-thiazol-2-yl]-2,2-dimethyl-propionamide
- N-[5-[2-(5-chloro-2-methoxyanilino)-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]-2,2-dimethylpropanamide
- N-[5-[2-(5-chloro-2-methoxyanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]-2,2-dimethylpropanamide
- N-[5-[2-[(5-chloranyl-2-methoxy-phenyl)amino]-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]-2,2-dimethyl-propanamide
- SMR000156108
- cid_11958611
|
BDBM101262
 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Amine oxidase (flavin-containing) A
- Amine oxidase [flavin-containing] B
- Lysine-specific histone demethylase 1A
| - US8524717, 17
- US8524717, 32
|
BDBM102131
 | 4 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 2
| |
BDBM102133
 | 4 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 2
| - CHEMBL2435408
- US8530648, 30
|
BDBM102136
 | 4 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 2
| |
BDBM102168
 | 4 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 2
| |
BDBM102169
 | 4 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 2
| |
BDBM102171
 | 4 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 2
| |
BDBM102172
 | 4 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 2
| |
BDBM102173
 | 4 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 2
| |
BDBM10247
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-2
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
- Heat shock protein HSP 90-beta
| - 1,2,3,4-tetrahydroisoquinoline-1,3,4-trione
- Isoquinoline-1,3,4-trione 1
- hsp90_153
|
BDBM102563
 | 0 | 5 | 1 | 0 | 0 | 0 | 0 | 0 | - Mitogen-activated protein kinase 8
- Mitogen-activated protein kinase 9
- c-Jun N-terminal kinase, JNK
| |
BDBM103297
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Cytochrome P450 3A
- MAP kinase ERK1
- Mitogen-activated protein kinase 1
| |
BDBM10332
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - (S)-1-(4-Methylthiobenzyl)-5-(2-phenoxymethyl-pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione
- 1-{[4-(methylsulfanyl)phenyl]methyl}-5-{[(2S)-2-(phenoxymethyl)pyrrolidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Pyrrolidine Isatin Analogue 11d
|
BDBM10333
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - 4-[(2,3-dioxo-5-{[(2S)-2-(phenoxymethyl)pyrrolidine-1-]sulfonyl}-2,3-dihydro-1H-indol-1-yl)methyl]phenyl acetate
- Acetic Acid (S)-4-[2,3-Dioxo-5-(2-phenoxymethyl-pyrrolidine-1-sulfonyl)-2,3-dihydroindol-1-yl-methyl]phenyl Ester
- Pyrrolidine Isatin Analogue 11e
|
BDBM10335
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - (S)-1-(6-Fluoropyridin-3-yl-methyl)-5-(2-phenoxymethylpyrrolidine-1-sulfonyl)-1H-indole-2,3-dione
- 1-[(6-fluoropyridin-3-yl)methyl]-5-{[(2S)-2-(phenoxymethyl)pyrrolidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Pyrrolidine Isatin Analogue 11g
|
BDBM10336
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - (S)-1-(2-Fluoro-pyridin-4-yl-methyl)-5-(2-phenoxymethyl-pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione
- 1-[(2-fluoropyridin-4-yl)methyl]-5-{[(2S)-2-(phenoxymethyl)pyrrolidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Pyrrolidine Isatin Analogue 11h
|
BDBM10337
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - (S)-1-(6-Fluoro-pyridin-2-yl-methyl)-5-(2-phenoxymethyl-pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione
- 1-[(6-fluoropyridin-2-yl)methyl]-5-{[(2S)-2-(phenoxymethyl)pyrrolidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Pyrrolidine Isatin Analogue 11i
|
BDBM10342
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - (S)-1-(4-Methylthiobenzyl)-5-(2-phenoxymethyl-azetidine-1-sulfonyl)-1H-indole-2,3-dione
- 1-{[4-(methylsulfanyl)phenyl]methyl}-5-{[(2S)-2-(phenoxymethyl)azetidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Azetidine Isatin Analogue 18d
|
BDBM10343
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - (S)-1-(4-Fluorobenzyl)-5-(2-phenoxymethyl-azetidine-1-sulfonyl)-1H-indole-2,3-dione
- 1-[(4-fluorophenyl)methyl]-5-{[(2S)-2-(phenoxymethyl)azetidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Azetidine Isatin Analogue 18e
|
BDBM10344
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - (S)-1-(2-Fluorobenzyl)-5-(2-phenoxymethyl-azetidine-1-sulfonyl)-1H-indole-2,3-dione
- 1-[(2-fluorophenyl)methyl]-5-{[(2S)-2-(phenoxymethyl)azetidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Azetidine Isatin Analogue 18f
|
BDBM10345
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - (S)-1-(6-Fluoropyridin-3-ylmethyl)-5-(2-phenoxymethyl-azetidine1-sulfonyl)-1H-indole-2,3-dione
- 1-[(6-fluoropyridin-3-yl)methyl]-5-{[(2S)-2-(phenoxymethyl)azetidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Azetidine Isatin Analogue 18g
|
BDBM10346
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - (S)-1-(2-Fluoropyridin-4-yl-methyl)-5-(2-phenoxymethyl-azetidine1-sulfonyl)-1H-indole-2,3-dione
- 1-[(2-fluoropyridin-4-yl)methyl]-5-{[(2S)-2-(phenoxymethyl)azetidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Azetidine Isatin Analogue 18h
|
BDBM10347
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - (S)-1-(6-Fluoropyridin-2-yl-methyl)-5-(2-phenoxymethyl-azetidine--1-sulfonyl)-1H-indole-2,3-dione
- 1-[(6-fluoropyridin-2-yl)methyl]-5-{[(2S)-2-(phenoxymethyl)azetidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Azetidine Isatin Analogue 18i
|
BDBM103506
 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - 5-hydroxytryptamine receptor 2B
- 5-hydroxytryptamine receptor 6
- Potassium voltage-gated channel subfamily H member 2
| - CHEMBL2172186
- US8552017, 1.1(3).HCl
|
BDBM10352
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - 1-(4-Methylthiobenzyl)-5-(2-(pyridin-3-yl-oxymethyl)-pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione
- 1-{[4-(methylsulfanyl)phenyl]methyl}-5-{[(2S)-2-[(pyridin-3-yloxy)methyl]pyrrolidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Pyridine Analogue 21d
|
BDBM10353
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - 1-(4-Fluorobenzyl)-5-(2-(pyridin-3-yl-oxymethyl)-pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione
- 1-[(4-fluorophenyl)methyl]-5-{[(2S)-2-[(pyridin-3-yloxy)methyl]pyrrolidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Pyridine Analogue 21e
|
BDBM103533
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Cereblon/Histone deacetylase 1
- Histone deacetylase 1
- Histone deacetylase 8
| - US10201527, Compound 3
- US10736881, Compound 3
- US8551988, 3
|
BDBM103535
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Cereblon/Histone deacetylase 1
- Histone deacetylase 1
- Histone deacetylase 8
| - US10201527, Compound 5
- US10736881, Compound 5
- US8551988, 5
|
BDBM103536
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Cereblon/Histone deacetylase 1
- Histone deacetylase 1
- Histone deacetylase 8
| - US10201527, Compound 6
- US10736881, Compound 6
- US8551988, 6
|
BDBM103537
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Cereblon/Histone deacetylase 1
- Histone deacetylase 1
- Histone deacetylase 8
| - US10201527, Compound 7
- US10736881, Compound 7
- US8551988, 7
|
BDBM103538
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Cereblon/Histone deacetylase 1
- Histone deacetylase 1
- Histone deacetylase 8
| - US10201527, Compound 8
- US10736881, Compound 8
- US8551988, 8
|
BDBM103539
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Cereblon/Histone deacetylase 1
- Histone deacetylase 1
- Histone deacetylase 8
| - US10201527, Compound 9
- US10736881, Compound 9
- US8551988, 9
|
BDBM10354
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-6
- Caspase-7
- Caspase-8
| - 5-(2-(Pyridin-4-yl-oxymethyl)-pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione
- 5-{[(2S)-2-[(pyridin-4-yloxy)methyl]pyrrolidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- Pyridine Analogue 23
|
BDBM103540
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Cereblon/Histone deacetylase 1
- Histone deacetylase 1
- Histone deacetylase 8
| - US10201527, Compound 10
- US10736881, Compound 10
- US8551988, 10
|
BDBM103541
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Cereblon/Histone deacetylase 1
- Histone deacetylase 1
- Histone deacetylase 8
| - US10201527, Compound 11
- US10736881, Compound 11
- US8551988, 11
|
BDBM103543
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Cereblon/Histone deacetylase 1
- Histone deacetylase 1
- Histone deacetylase 8
| - US10201527, Compound 13
- US10736881, Compound 13
- US8551988, 13
|
BDBM103544
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Cereblon/Histone deacetylase 1
- Histone deacetylase 1
- Histone deacetylase 8
| - US10201527, Compound 18
- US10736881, Compound 18
- US8551988, 18
|
BDBM103545
 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | - Cereblon/Histone deacetylase 1
- Histone deacetylase 1
- Histone deacetylase 8
| - US10201527, Compound 22
- US10736881, Compound 22
- US8551988, 22
|
BDBM103546
 | 0 | 6 | 0 | 0 | 0 | 0 |